ArticleMolecular cancer therapeutics2010

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.

Eun Sung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.